System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Falko Fend is an expert in Hematology at Universitätsklinikum Tübingen (Germany). As of October 2026, ScienceLeadR ranks Falko Fend in the top 1% of experts worldwide for Lymphoma and Lymphoproliferative Disorders. Falko Fend has authored 637 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 1 of them ongoing. SLR score: 1,639 (community average: 125). How the SLR is computed.

LeadR Profile

Falko Fend Universitätsklinikum Tübingen Germany
1 639 ScienceLeadR Reputation 1639

Unlock

Register Login
Network Map

Hematology

Subspecialties: Oncology - Immunology - Ophthalmology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1989 - 2026
Source: PubMed

Universitätsklinikum Tübingen

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 637

Citations

Citations: 19 675 1st author: 43 Last author: 100 Unique author: 16

Main journals

Blood 42
Virchows Arch 38
Pathologe 28
Mod Pathol 17
Br J Haematol 14

Best Journals

Lancet 1
Nature 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma.
PMID 42520200 — cells, hematology, lymphoma, immunotherapy, immunity, t-lymphocytes, lymphoma, t-cell		Blood20260
Gene-radon interaction effects on lung cancer risk: validation of susceptibility loci using archived DNA from German Uranium miners.
PMID 42947277 — dust, genes, lung, neoplasms, lung neoplasms, alleles, environment		Genes Environ20260
Rare But Specific B-Cell Receptor Reactivity Against Coxsackievirus A24 in Primary Central Nervous System Lymphomas.
PMID 42856814 — cells, antigens, viral, lymphoma, neoplasms, central nervous system, nervous system, b-lymphocytes, neurabins		EJHaem20260
Genomic correlates of metastatic competence and progression in human melanoma.
PMID 42856273 — genes, melanoma, point mutation, neoplasm metastasis, clone cells, chromosomal instability, mutation		bioRxiv20260
Molekulare Pathologie als Innovationstreiber und Garant einer optimierten onkologischen Versorgung.
PMID 42360475 — pathology, pathologic processes		Pathologie (Heidelb)20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3
Phase 1/Phase 2 1
Phase 2 1

By status:

Completed 2
Recruiting 2
Enrolling by invitation 1

By type:

Interventional 3
Observational 2

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
PAX5 NEGATIVE HODGKIN LIKE LYMPHOMAS A DIAGNOSTIC CHALLANGE
NCT07313943 — cells, absenteeism, lymphocytes, hodgkin disease, lymphoma, neoplasms, diagnosis, lymphoma, non-hodgkin, t-lymphocytes, b-lymphocytes		N/ARecruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS